2015Unpublished venueRequires access

The lipid Metabolism of Zhibitai in liver dysfunction

Lingyun Chen

Open publisher page 0 citations

Abstract

Objective To analyze the lipid levels in liver damage. Methods 82 patients with liver damage were divided into the study group(41 patients)and control group(41 patients), the control group patients were given treatment of atorvastatin, while the study group patients were given treatment of Zhibitai, the lipid metabolism of the two groups were compared. Results In the study group,levels of TC(5.16±0.8)mmol/L,TG (1.90±0.08)mmol/L,LDL(2.03±0.11)mmol/L were significantly lower than before treatment TC(5.82±1.26)mmol/L(t=4.38,P<0.05),TG(2.16±0.85)mmol/L(t=6.37,P<0.05),LDL(3.67±0.09)mmol/L(t =6.42).The HDL level(1.39±0.26)mmol/L was significantly increased(0.86±0.21)mmol/L(t=7.52,P< 0.05)after 4 weeks treatment(P<0.05).The incidence of adverse events in the study group(7.3%)was significantly lower than the control group(17.1%)(P<0.05). Conclusion Zhibitai is safe and effective with use value in the treatment of liver dysfunction. Key words: Liver damage; Zhibitai; Lipid; Atorvastatin

About this research paper

What this paper is about

Objective To analyze the lipid levels in liver damage. Methods 82 patients with liver damage were divided into the study group(41 patients)and control group(41 patients), the control group patients were given treatment of atorvastatin, while the study group patients were given treatment of Zhibitai, the lipid metabolism of the two groups were compared. Results In the study group,levels of TC(5.16±0.8)mmol/L,TG (1.90±0.08)mmol/L,LDL(2.03±0.11)mmol/L were significantly lower than before treatment TC(5.82±1.26)mmol/L(t=4.38,P<0.05),TG(2.16±0.85)mmol/L(t=6.37,P<0.05),LDL(3.67±0.09)mmol/L(t =6.42).The HDL level(1.39±0.26)mmol/L was significantly increased(0.86±0.21)mmol/L(t=7.52,P< 0.05)after 4 weeks treatment(P<0.05).The incidence of adverse events in the study group(7.3%)was significantly lower than the control group(17.1%)(P<0.05). Conclusion Zhibitai is safe and effective with use value in the treatment of liver dysfunction. Key words: Liver damage; Zhibitai; Lipid; Atorvastatin

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To analyze the lipid levels in liver damage. Methods 82 patients with liver damage were divided into the study group(41 patients)and control group(41 patients), the control group patients were given treatment of atorvastatin, while the study group patients were given treatment of Zhibitai, the lipid metabolism of the two groups were compared. Results In the study group,levels of TC(5.16±0.8)mmol/L,TG (1.90±0.08)mmol/L,LDL(2.03±0.11)mmol/L were significantly lower than before treatment TC(5.82±1.26)mmol/L(t=4.38,P<0.05),TG(2.16±0.85)mmol/L(t=6.37,P<0.05),LDL(3.67±0.09)mmol/L(t =6.42).The HDL level(1.39±0.26)mmol/L was significantly increased(0.86±0.21)mmol/L(t=7.52,P< 0.05)after 4 weeks treatment(P<0.05).The incidence of adverse events in the study group(7.3%)was significantly lower than the control group(17.1%)(P<0.05). Conclusion Zhibitai is safe and effective with use value in the treatment of liver dysfunction. Key words: Liver damage; Zhibitai; Lipid; Atorvastatin

Key concepts: Medicine, Internal medicine, Atorvastatin, Gastroenterology, Lipid metabolism, Incidence (geometry), Metabolism, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
The lipid Metabolism of Zhibitai in liver dysfunction — Research Paper | ScholarLens